List of Related Excipient Companies and Suppliers of Fesoterodine on PharmaCompass.com

PharmaCompass

Synopsis

Synopsis

API REF. PRICE (USD/KG)

MARKET PLACE

0

FDF

FINISHED DOSAGE FORMULATIONS

0

Australia

Australia

0

South Africa

South Africa

FDF DossiersDRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 286930-03-8, Toviaz, (r)-fesoterodine fumarate, Spm 907, Spm 8272, Spm-907
Molecular Formula
C30H41NO7
Molecular Weight
527.6  g/mol
InChI Key
MWHXMIASLKXGBU-RNCYCKTQSA-N
FDA UNII
EOS72165S7

Fesoterodine
Fesoterodine Fumarate is the fumarate salt form of fesoterodine, a competitive muscarinic receptor antagonist with muscle relaxant and urinary antispasmodic properties. Fesoterodine is rapidly hydrolyzed in vivo into its active metabolite 5-hydroxy methyl tolterodine, which binds and inhibits muscarinic receptors on the bladder detrusor muscle, thereby preventing bladder contractions or spasms caused by acetylcholine. This results in the relaxation of bladder smooth muscle and greater bladder capacity, in addition to a reduction in involuntary muscle contractions and involuntary loss of urine. The active metabolite does not interact with alpha-adrenergic, serotonergic, histaminergic and excitatory amino acid receptors and is eliminated via renal excretion.
1 2D Structure

Fesoterodine

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(E)-but-2-enedioic acid;[2-[(1R)-3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenyl] 2-methylpropanoate
2.1.2 InChI
InChI=1S/C26H37NO3.C4H4O4/c1-18(2)26(29)30-25-13-12-21(17-28)16-24(25)23(22-10-8-7-9-11-22)14-15-27(19(3)4)20(5)6;5-3(6)1-2-4(7)8/h7-13,16,18-20,23,28H,14-15,17H2,1-6H3;1-2H,(H,5,6)(H,7,8)/b;2-1+/t23-;/m1./s1
2.1.3 InChI Key
MWHXMIASLKXGBU-RNCYCKTQSA-N
2.1.4 Canonical SMILES
CC(C)C(=O)OC1=C(C=C(C=C1)CO)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2.C(=CC(=O)O)C(=O)O
2.1.5 Isomeric SMILES
CC(C)C(=O)OC1=C(C=C(C=C1)CO)[C@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2.C(=C/C(=O)O)\C(=O)O
2.2 Other Identifiers
2.2.1 UNII
EOS72165S7
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Fesoterodine

2. Toviaz

2.3.2 Depositor-Supplied Synonyms

1. 286930-03-8

2. Toviaz

3. (r)-fesoterodine Fumarate

4. Spm 907

5. Spm 8272

6. Spm-907

7. Spm-8272

8. Fesoterodine Maleate

9. Fesoterodine (fumarate)

10. Eos72165s7

11. (e)-but-2-enedioic Acid;[2-[(1r)-3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenyl] 2-methylpropanoate

12. Propanoic Acid, 2-methyl-, 2-[(1r)-3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenyl Ester, (2e)-2-butenedioate (1:1)

13. 286930-03-8 (fumarate); 286930-02-7 (free Base)

14. Fesoterodine Fumarate [usan]

15. Unii-eos72165s7

16. Fesoterodine Fumarate [usan:jan]

17. (e)-but-2-enedioic Acid,[2-[(1r)-3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenyl] 2-methylpropanoate

18. Toviaz (tn)

19. (r)-fesoterodinefumarate

20. Mls003915638

21. Schembl814971

22. Fesoterodine Fumarate - Toviaz

23. Schembl1993632

24. Chembl1201765

25. Dtxsid00904655

26. Bcpp000231

27. Fesoterodine Fumarate (jan/usan)

28. Fesoterodine Fumarate [mi]

29. Hms3884d11

30. Fesoterodine Fumarate [jan]

31. Amy37611

32. Hy-a0030

33. Bdbm50248002

34. Fesoterodine Fumarate [vandf]

35. Mfcd12756004

36. S2240

37. Fesoterodine Fumarate [mart.]

38. Akos005146248

39. Akos015855886

40. Fesoterodine Fumarate [who-dd]

41. Ac-3486

42. Bcp9000682

43. Ccg-269901

44. Cs-0822

45. Ks-1298

46. 2-((1r)-3-(diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenyl Isobutyrate

47. Fesoterodine Fumarate [ema Epar]

48. 2-((1r)-3-(bis(1-methylethyl)amino)-1-phenylpropyl)-4-(hydroxymethyl)phenyl 2-methylpropanoate Hydrogen (2e)-butenedioate (salt)

49. Propanoic Acid, 2-methyl-, 2-((1r)-3-(bis(1-methylethyl)amino)-1-phenylpropyl)-4-(hydroxymethyl)phenyl Ester, (2e)-2-butenedioate (1:1) (salt)

50. Smr002544691

51. Fesoterodine Fumarate [orange Book]

52. Pf-00695838

53. D08923

54. 930f038

55. A846296

56. Q27277274

57. 2-((1r)-3-(bis(1-methylethyl)amino)-1-phenylpropyl)-4-(hydroxymethyl)phenyl 2-methylpropanoate Hydrogen(2e)-butenedioate (salt)

58. Fesoterodinefumarate;(r)-fesoterodine Fumarate;2-methylpropanoic Acid 2-[(1r)-3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenyl Ester (2e)-2-butenedioate

59. Propanoic Acid,2-methyl ,2-((1r)-3-(bis(1-methylethyl)amino)-1-phenylpropyl)-4-(hydroxymethyl)phenyl Ester,(2e)-2-butenedioate (1:1)(salt)

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 527.6 g/mol
Molecular Formula C30H41NO7
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count8
Rotatable Bond Count13
Exact Mass527.28830265 g/mol
Monoisotopic Mass527.28830265 g/mol
Topological Polar Surface Area124 Ų
Heavy Atom Count38
Formal Charge0
Complexity610
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameToviaz
PubMed HealthFesoterodine (By mouth)
Drug ClassesUrinary Antispasmodic
Drug LabelToviaz contains fesoterodine fumarate and is an extended-release tablet. Fesoterodine is rapidly de-esterified to its active metabolite (R)-2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxymethyl-phenol, or 5-hydroxymethyl tolterodine, which is a musca...
Active IngredientFesoterodine fumarate
Dosage FormTablet, extended release
RouteOral
Strength8mg; 4mg
Market StatusPrescription
CompanyPfizer

2 of 2  
Drug NameToviaz
PubMed HealthFesoterodine (By mouth)
Drug ClassesUrinary Antispasmodic
Drug LabelToviaz contains fesoterodine fumarate and is an extended-release tablet. Fesoterodine is rapidly de-esterified to its active metabolite (R)-2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxymethyl-phenol, or 5-hydroxymethyl tolterodine, which is a musca...
Active IngredientFesoterodine fumarate
Dosage FormTablet, extended release
RouteOral
Strength8mg; 4mg
Market StatusPrescription
CompanyPfizer

4.2 Drug Indication

Treatment of the symptoms (increased urinary frequency and / or urgency and / or urgency incontinence) that may occur in patients with overactive-bladder syndrome.


5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Muscarinic Antagonists

Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. (See all compounds classified as Muscarinic Antagonists.)


Urological Agents

Drugs used in the treatment of urological conditions and diseases such as URINARY INCONTINENCE and URINARY TRACT INFECTIONS. (See all compounds classified as Urological Agents.)


5.2 ATC Code

G04BD11


API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1695666600,"product":"FESOTERODINE FUMARATE","address":"RAKSHIT HOUSE 425\/3RT,DNO.7-1-621\/","city":"HYDERABAD. AP.","supplier":"RAKS PHARMA","supplierCountry":"INDIA","foreign_port":"NEW YORK - JOHN F. K","customer":"AMNEAL PHARMACEUTICALS","customerCountry":"UNITED STATES","quantity":"8.06","actualQuantity":"8.06","unit":"KGS","unitRateFc":"4170","totalValueFC":"33322","currency":"USD","unitRateINR":343176.17866004963,"date":"26-Sep-2023","totalValueINR":"2766000","totalValueInUsd":"33322","indian_port":"Hyderabad Air","hs_no":"29420090","bill_no":"4189389","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"RAKSHIT HOUSE 425\/3RT,DNO.7-1-621\/, HYDERABAD. AP.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1697135400,"product":"DESFESOTERODINE SUCCINATE CONTROL BATCHNO. 9301000323 MFG DT.SEPTEMBER 2023 RETEST. DT.AUGUST 2026","address":"M-34, SAKET,","city":"NEW DELHI,DELHI","supplier":"TEVA API","supplierCountry":"INDIA","foreign_port":"MUNICH","customer":"MERCKLE GMBH","customerCountry":"GERMANY","quantity":"16.07","actualQuantity":"16.07","unit":"KGS","unitRateFc":"6597.6","totalValueFC":"104350.3","currency":"USD","unitRateINR":540448.03982576227,"date":"13-Oct-2023","totalValueINR":"8685000","totalValueInUsd":"104350.3","indian_port":"Delhi Air","hs_no":"29225090","bill_no":"4612585","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"Delhi Air","supplierAddress":"M-34, SAKET,, NEW DELHI,DELHI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1702319400,"product":"FESOTERODINE FUMARATE","address":"PLOT NO. C-24, INDUSTRIAL ESTATE,","city":"HYDERABAD. AP","supplier":"MAITHRI LABORATORIES PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"BILIM PHARMACEUTICALS","customerCountry":"TURKEY","quantity":"4.00","actualQuantity":"4","unit":"KGS","unitRateFc":"7500","totalValueFC":"29756.2","currency":"USD","unitRateINR":619250,"date":"12-Dec-2023","totalValueINR":"2477000","totalValueInUsd":"29756.2","indian_port":"Hyderabad Air","hs_no":"29214190","bill_no":"5976786","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PLOT NO. C-24, INDUSTRIAL ESTATE,, HYDERABAD. AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1703788200,"product":"DESFESOTERODINE SUCCINATE CONTROL BATCHNO. 9301000623 MFG DT.SEPTEMBER 2023 RETEST. DT.AUGUST 2026","address":"M-34, SAKET,","city":"NEW DELHI,DELHI","supplier":"TEVA API","supplierCountry":"INDIA","foreign_port":"MUNICH","customer":"MERCKLE GMBH","customerCountry":"GERMANY","quantity":"16.05","actualQuantity":"16.05","unit":"KGS","unitRateFc":"6597.6","totalValueFC":"104585.2","currency":"USD","unitRateINR":542429.90654205601,"date":"29-Dec-2023","totalValueINR":"8706000","totalValueInUsd":"104585.2","indian_port":"Delhi Air","hs_no":"29225090","bill_no":"6389536","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"Delhi Air","supplierAddress":"M-34, SAKET,, NEW DELHI,DELHI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1707071400,"product":"FESOTERODINE FUMARATE","address":"PLOT NO. C-24, INDUSTRIAL ESTATE,","city":"HYDERABAD. AP","supplier":"MAITHRI LABORATORIES PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"ATHENS","customer":"RONTIS","customerCountry":"GREECE","quantity":"160.00","actualQuantity":"160","unit":"KGS","unitRateFc":"3300","totalValueFC":"523382.9","currency":"USD","unitRateINR":271419.10625000001,"date":"05-Feb-2024","totalValueINR":"43427057","totalValueInUsd":"523382.9","indian_port":"Hyderabad Air","hs_no":"29214190","bill_no":"7285414","productDescription":"API","marketType":"REGULATED MARKET","country":"GREECE","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PLOT NO. C-24, INDUSTRIAL ESTATE,, HYDERABAD. AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1710873000,"product":"FESOTERODINE FUMARATE","address":"PLOT NO. C-24, INDUSTRIAL ESTATE,","city":"HYDERABAD. AP","supplier":"MAITHRI LABORATORIES PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"ATHENS","customer":"RONTIS","customerCountry":"GREECE","quantity":"160.00","actualQuantity":"160","unit":"KGS","unitRateFc":"3300","totalValueFC":"521413.7","currency":"USD","unitRateINR":270600,"date":"20-Mar-2024","totalValueINR":"43296000","totalValueInUsd":"521413.7","indian_port":"Hyderabad Air","hs_no":"29214190","bill_no":"8482325","productDescription":"API","marketType":"REGULATED MARKET","country":"GREECE","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PLOT NO. C-24, INDUSTRIAL ESTATE,, HYDERABAD. AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1717612200,"product":"DESFESOTERODINE SUCCINATE - CONTROL BATCH NO 9301000124 MFG DT MAY 2024 RETEST DT.MAY 2027","address":"M-34, SAKET,","city":"NEW DELHI,DELHI","supplier":"TEVA API","supplierCountry":"INDIA","foreign_port":"MUNICH","customer":"MERCKLE GMBH","customerCountry":"GERMANY","quantity":"5.15","actualQuantity":"5.15","unit":"KGS","unitRateFc":"6969","totalValueFC":"34415.2","currency":"USD","unitRateINR":557856.45436893206,"date":"06-Jun-2024","totalValueINR":"2872960.74","totalValueInUsd":"34415.2","indian_port":"Delhi Air","hs_no":"29225090","bill_no":"1471110","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"Delhi Air","supplierAddress":"M-34, SAKET,, NEW DELHI,DELHI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1721241000,"product":"FESOTERODINE FUMARATE","address":"PLOT NO. C-24, INDUSTRIAL ESTATE,","city":"HYDERABAD. AP","supplier":"MAITHRI LABORATORIES PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"TOKYO","customer":"CBC GROUP","customerCountry":"JAPAN","quantity":"0.03","actualQuantity":"0.03","unit":"KGS","unitRateFc":"50000","totalValueFC":"1375.3","currency":"USD","unitRateINR":3832033.3333333335,"date":"18-Jul-2024","totalValueINR":"114961","totalValueInUsd":"1375.3","indian_port":"Hyderabad Air","hs_no":"29214190","bill_no":"2510526","productDescription":"API","marketType":"REGULATED MARKET","country":"JAPAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PLOT NO. C-24, INDUSTRIAL ESTATE,, HYDERABAD. AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1723746600,"product":"ACTIVE PHARMACEUTICALS INGREDIENTS (PHARMACEUTICALS RAW MATERIAL FOR PHARMA INDUSTRIES) FESOTERODINE FUMARATE","address":"ALEMBIC ROAD","city":"GUJARAT","supplier":"ALEMBIC PHARMACEUTICALS LIMITED","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"TO THE ORDER OF","customerCountry":"TURKEY","quantity":"7.89","actualQuantity":"7.89","unit":"KGS","unitRateFc":"4000","totalValueFC":"30935.3","currency":"USD","unitRateINR":328873.46387832699,"date":"16-Aug-2024","totalValueINR":"2594811.63","totalValueInUsd":"30935.3","indian_port":"Ahmedabad Air","hs_no":"29420090","bill_no":"3256329","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"Ahmedabad Air","supplierAddress":"ALEMBIC ROAD, GUJARAT","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1721586600,"product":"FESOTERODINE FUMARATE MICRO","address":"PLOT NO.2, MAITRIVIHAR,","city":"HYDERABAD\/ANDHRA PRADESH","supplier":"DIPHARMA","supplierCountry":"MALTA","foreign_port":"MALTA","customer":"AUROBINDO PHARMA LIMITED","customerCountry":"INDIA","quantity":"9.00","actualQuantity":"9","unit":"KGS","unitRateFc":"16720","totalValueFC":"152206.1","currency":"USD","unitRateINR":"1413675","date":"22-Jul-2024","totalValueINR":"12723075","totalValueInUsd":"152206.1","indian_port":"SEZ\/Mahaboobnagar","hs_no":"29225090","bill_no":"1002357","productDescription":"API","marketType":"REGULATED MARKET","country":"MALTA","selfForZScoreResived":"Pharma Grade","supplierPort":"MALTA","supplierAddress":"VIA BISSONE 5 BARANZATE 20021 ITALY","customerAddress":"PLOT NO.2, MAITRIVIHAR,"}]
26-Sep-2023
16-Aug-2024
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 4MG

USFDA APPLICATION NUMBER - 22030

read-more

DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 8MG

USFDA APPLICATION NUMBER - 22030

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Coating Systems & Additives

read-more
read-more

Controlled & Modified Release

read-more
read-more

Direct Compression

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Granulation

read-more
read-more

Co-Processed Excipients

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Solubilizers

read-more
read-more

Lubricants & Glidants

read-more
read-more

Topical

read-more
read-more

Taste Masking

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Parenteral

read-more
read-more

Empty Capsules

read-more
read-more

API Stability Enhancers

read-more
read-more

Vegetarian Capsules

read-more
read-more

Coloring Agents

read-more
read-more

Rheology Modifiers

read-more
read-more

Emulsifying Agents

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty